Complementary and alternative medicine use among ambulatory diabetes patients in a South-Western tertiary hospital in Nigeria
Main Article Content
Abstract
Background: Diabetes mellitus (DM) is a chronic disease with an increasing incidence and prevalence worldwide while complementary and alternative medicine (CAM) is an emerging aspect in DM management. The use of CAM among DM patients has not been widely studied in Nigeria.
Objectives: To study the prevalence and pattern of use of CAM and to identify reasons for their use among DM patients in a University Teaching Hospital in South-Western Nigeria.
Method: Semi-structured questionnaire was administered to 119 diabetes patients. Socio-demographic data, prescribed medications, pattern of CAM use and patient's disclosure of CAM were documented. Data was organized using SPSS statistics version 20 and analysis was done using chi-square test.
Result: A response rate of 95% was obtained. Age range of study participants was 40-90 years with 72.6% above 60years of age. Duration of use of DM medication among patients ranged from 4 months to 33 years. The prevalence rate of CAM use was 69% with biological based therapies being the only form of CAM used. Patients who had been on DM medication for more than 4 years made up 75.3% of CAM users and used more CAM combinations. Patients were introduced to CAM mainly by friends (41%) and neighbours (38.5%). Only 9% of CAM users told their physicians about their use of CAM.
Conclusion: CAM is becoming an important aspect in the management of DM which should be studied and explored. Healthcare practitioners need to be open-minded about the use of CAM so as to give adequate information to help patients make informed decision for the goal of achieving better therapeutic outcomes.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
American Diabetes Association (2011). Diagnosis and Classification of Diabetes Mellitus: Definition and Description of Diabetes Mellitus. Diabetes Care 34(1): S62 – S69. [DOI: 10.2337/dc11-S062]
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003). Follow-up report on the diagnosis of diabetes mellitus.
Diabetes Care; 26: 3160-3167.
Ogbera and Ekpebegh, C. (2014). Diabetes mellitus in Nigeria: The past, present and future. World Journal Diabetes. 15; 5(6): 905-911.
World Health Organisation (2015). WHO Media Centre. http://www.who.int/mediacentre/factsheets/fs138/en. Assessed on 2/6/2018
Kengne AP, Amoah AG. andMbanya JC (2005). Cardiovascular complications of diabetes mellitus in sub-Saharan Africa. Circulation 112: 3592-360.
Dey L, Attele AS and Yuan C (2002). Alternative therapies for type 2 diabetes. Alternative Medicine Review 7(1): 45-58.
Onyiapat JE, Okoronkwo IL and Ogbonnaya NP (2011). Complementary and alternative medicine use among adults in Enugu, Nigeria. BMC
Complementary and alternative medicine. 11:19.
Rosenberg EI, Genao I, Chen I, Mechaber AJ, Wood JA, Faselis CJ, Kurz J, Menon M, O'rorke J, Panda M, Pasanen M, Staton L, Calleson D and Cykert S (2008). Complementary and alternative medicine use by primary care patients with chronic pain. Pain Med 9(8): 1065-1072.
Ogbera AO, Dada O, Adeleye F and Jewo PI (2010). Complementary and Alternative Medicine Use in Diabetes Mellitus. West African Journal of Medicine 29(3): 158-161.
Yeh GY, Eisenberg DM, Davis RB and Philips RS (2002). Use of complementary and alternative medicine among persons with diabetes mellitus: results of a national survey. American Journal of Public Health, 92 (10): 1648-1652.
Idung AU, Okokon IB, Udoh SB and Inem VA (2014). Clinical and Socio Demographic Profiles of Complementary and Alternative Medicine Users among Outpatient Clinic Attendees in Uyo, SouthSouth Nigeria. Family Medicine and Medical Science Research. 3: 117.
Bailey CJ and Day C (1989). Traditional plant medicines as treatments for diabetes. Diabetes Care 12:553-564.
Araoye MO (2003). Subjects selection: Research methodology with statistics for health and social sciences. 1st ed. Nathadex Publishers, Ilorin, Nigeria 117-120.
Garrow D and Egede LE (2006). National patterns and correlates of complementary and alternative medicine use in adults with diabetes. Journal of Alternative and Complementary Medicine 12(9): 895-902.
Ryan E, Pick M and Marceau C (2001). Use of Alternative Medicines in diabetes mellitus. Diabetes Med 18(3):242–245.
Argaez-Lopez N, Wacher N H, Kumate-Rodriguez J, Cruz M, Talavera J, Rivera-Arce E and Lozoya X (2003). DIMSS Study Group: The use of
complementary and alternative medicine therapies in type 2 diabetic patients in Mexico. Diabetes Care, 26(8):2470–2471.
Kumar D, Bajaj S and Mehrotra R (2006). Knowledge, attitude and practice of complementary and alternative medicines for diabetes. Public Health 120(8): 705-711.
Upchurch DM and Raninisch BK (2012). Racial and Ethnic Profiles of Complementary and Alternative Medicine Use among Young Adults in the United States: Findings From the National Longitudinal Study of Adolescent Health. Journal of Evidence Based Complementary and Alternative Medicine17(3): 172-179.
Akinloye OO and Yinusa R (2011). Assessment of complementary and alternative medicine (CAM) usage to enhance male sexual performance in Ogbomoso metropolis. Journal of Public Health and Epidemiology271-274.
Naja F, Mousa D, Alamedddine M, Shoaib H, Itani L and Mourad Y (2014). Prevalence and correlates of complementary and alternative medicine use among diabetic patients in Beirut, Lebanon: a crosssectional study. BMC Complementary and Alternative Medicine 14: 185. http://www.biomedcentral.com/1472-6882/14/185. Assessed on 2/6/2018.
Saydah SH and Eberhardt MS (2006). Use of Complementary and Alternative Medicine among Young Adults with Chronic Diseases: United States 2 0 0 2 . The Journal of Alternative and Complementary Medicine 12 (8) [DOI: 10.1089/acm.2006.12.805]
Ogbera AO and Kuku SF (2012). Insulin use, prescription patterns, regimens and costs.-a narrative from a developing country. Diabetology
and Metabolic Syndrome 4: 50 [DOI:10.1186/1758-5996-4-50]
Mbanya JC, Motala AA, Sobngwi E, Assah FK and Enoru ST (2010). Diabetes in Sub-Saharan Africa. Lancet 375: 2254-2266.
Kesavadev J, Saboo B, Sadikat S, Das AK, Joshi S, Chawla R, Jhacker H, Shankar A, Rama Chandran L and Kalia S (2017). Unproven therapies for diabetes and their Implications. Advanced Therapy 34(1): 60 -77